Not sure if RHY shareholders are aware of an upcoming event (in two weeks) to be held in Chicago IIlinois from the 2nd to 6th June.
If anyone else has recently posted details - apologies.
As announced to the ASX on 6 April 2023, both abstracts submitted on ColoSTAT® at the 2023 Annual Meeting of the American Society for Clinical Oncology (ASCO) have been accepted.
The abstracts outlining the clinical data and economics for the adoption of ColoSTAT® in the USA will be available to an expected attendance of more than 40,000 healthcare professionals in the event. The event showcases the latest innovations in cancer research and education.
Surely, one would think this will give RHY much needed further exposure in USA.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)